Post Authorisation Safety Study (PASS): an European observational cohort of patients with type 1 diabetes treated via intraperitoneal route with Insuman Implantable 400 IU/mL in Medtronic MiniMed implantable pump (IIMOS)

First published 04/09/2015

Last updated 02/07/2024

EU PAS number:

EUPAS10872

Study

Finalised

Documents

Study protocol

Initial protocol

HUBINC06380-final protocol - December 2014

English (501.36 KB - PDF)View document

Updated protocol

hubin-c-06380-amended-protocol2_20FEB2018

First published: 22/02/2024

English (528.62 KB - PDF)View document

Study results

hubin-c-06380-final_CSR_abstract

English (619.43 KB - PDF)View document

Study report

Other information

Publications

Study publications

ENCePP Seal

ENCePP Seal documents

Composition of steering group and observers

HUBINC06380_SC_Members

English (12.88 KB - PDF)View document

Secondary tabs